PARTNER CONTENT
✕
NEWS ARCHIVE

Life heads for a corporate makeover

FAILED biotechnology company Life Therapeutics is looking to reinvent itself as an investment com...

Nick Evans

BioTechnologyNews, a sister publication of PetroleumNews.net, understands the company holds around $20 million in cash after the sale of its US plasma collection assets to Octopharma and has no other operational...

Start a free trial to continue reading this article

Already have an account?

Subscribe now
RELATED ARTICLES
MORE ON THIS TOPIC

FROM OUR PARTNERS

View more
PARTNER CONTENT

The time to secure Australia's energy future

PARTNER CONTENT

GeoVentus and ALARP Solutions join forces to support the resources sectors

MOST POPULAR
1
OPERATIONS

Cook to fight for Woodside if ExxonMobil seeks acquisition

2
OPERATIONS

Strike action set to take Ichthys offline within days

3
POLICY

Beach says govt's gas reservation scheme will worsen market's issues

4
OPERATIONS

Barossa FPSO passes milestone on the road to project's "practical completion"

RESEARCH

lock Premium subscribers only

View more

A growing series of reports, each focused on a key discussion point for the energy sector, brought to you by the Energy News Bulletin Intelligence team.

A growing series of reports, each focused on a key discussion point for the energy sector, brought to you by the Energy News Bulletin Intelligence team.

editions

Future of Energy: The Role of Batteries Report 2026

The role of batteries and storage in Australia’s energy transition

editions

Future of Energy Report: Nuclear Power in Australia 2024

Energy News Bulletin’s new report examines what the energy and resources industry thinks of the idea of a nuclear-powered Australia.

editions

ENB CCS Report 2024

ENB’s CCS Report 2024 finds that CCS could be the much-needed magic bullet for Australia’s decarbonisation drive

editions

ENB Cost Report 2023

ENB’s latest Cost Report findings provide optimism as investments in oil and gas, as well as new energy rise.

Content
About
Solutions
Legal

THE ASPERMONT BRAND PORTFOLIO

Copyright © 2026 Aspermont Ltd. All rights reserved, including those for text and data mining, AI training, and similar technologies. Aspermont Limited (ABN 66 000 375 048), Level 33, 152-158 St Georges Terrace, Perth WA 6000

Login